The report, presented by the Alliance for Patient Access (AfPA) and titled “Biosimilars: Can They Break Through?” will include discussion on the policy issues surrounding biosimilars in the United States. Topics will include:
- Given pending FDA regulations, what are the obstacles in getting biosimilars to market?
- What are the concerns surrounding the labeling or prescriber information, and why is the issue of naming so hotly contested?
People
Related Insights
27 May 2025
Events
The RIF Roadmap: Tools and Tactics for a Smooth and Compliant Transition
Join us for an insightful discussion on proactive workforce planning in today's dynamic economic and regulatory landscape.
16 May 2025
Manufacturing Industry Advisor
Reese’s Law: The Evolving Regulatory and Enforcement Landscape for Consumer Products Containing Button Cell or Coin Batteries
Over the past year, manufacturers, importers, distributors, and retailers of consumer products containing button cell and coin batteries (or products intended to contain them) have continued to adapt to the requirements of Reese’s Law and the Consumer Product Safety Commission’s corresponding enforcement efforts.
29 May 2025
Events
May 2025 Midwest Cyber Security Alliance Meeting | What Happens After a Breach: Practical Tips for the Notification Process
Join us on Thursday, May 29, 2025, at the next Midwest Cyber Security Alliance Meeting. Brandon Hollinder, Esq., and Adam Botter from Epiq will provide practical tips and insights on organizing the data mining and subsequent notification process after a cybersecurity breach.